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RepA-WH1 prionoid: Clues from bacteria on factors
governing phase transitions in amyloidogenesis
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ABSTRACT. In bacterial plasmids, Rep proteins initiate DNA replication by undergoing a structural
transformation coupled to dimer dissociation. Amyloidogenesis of the ‘winged-helix’ N-terminal
domain of RepA (WH1) is triggered in vitro upon binding to plasmid-specific DNA sequences, and
occurs at the bacterial nucleoid in vivo. Amyloid fibers are made of distorted RepA-WH1 monomers
that assemble as single or double intertwined tubular protofilaments. RepA-WH1 causes in E. coli an
amyloid proteinopathy, which is transmissible from mother to daughter cells, but not infectious, and
enables conformational imprinting in vitro and in vivo; i.e. RepA-WH1 is a ‘prionoid’. Microfluidics
allow the assessment of the intracellular dynamics of RepA-WH1: bacterial lineages maintain two
types (strains-like) of RepA-WH1 amyloids, either multiple compact cytotoxic particles or a single
aggregate with the appearance of a fluidized hydrogel that it is mildly detrimental to growth. The
Hsp70 chaperone DnaK governs the phase transition between both types of RepA-WH1 aggregates in
vivo, thus modulating the vertical propagation of the prionoid. Engineering chimeras between the
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Sup35p/[PSIC] prion and RepA-WH1 generates [REP-PSIC], a synthetic prion exhibiting strong and
weak phenotypic variants in yeast. These recent findings on a synthetic, self-contained bacterial
prionoid illuminate central issues of protein amyloidogenesis.
KEYWORDS. amyloid proteinopathy, amyloid polymorphism, bacterial prionoid, Hsp70
chaperone, phase transitions, RepA-WH1
INTRODUCTION
Along the last few years, the field of func-
tional amyloids, i.e., amyloid assemblies
with a physiological role and no proteino-
pathic side effects, has attracted much atten-
tion.1,2 Bacterial functional amyloids are
invariantly extracellular, acting as scaffold-
ing devices in building biofilms, three-
dimensional networks that serve to colonize
solid surfaces and confer to bacteria persis-
tence against chemotherapy with antibiotics.3
Amyloids also serve as inactive storage
deposits of the antimicrobial microcins.4 In
eukaryotic cells, functional amyloids are
either epigenetic determinants of non-Mende-
lian transmissible characters, as in the case
of yeast prions,5 or scaffolding modules, as
for mammalian Pmel17 in melanocytes;6 or
even regulators of long-term synaptic poten-
tiation, as proteins of the CPEB family from
mollusks to mice.7 Among functional amy-
loids, the ability of the Escherichia coli curli
system (CsgABC/CsgDEFG) to export nearly
any protein tagged to a CsgA-derived secre-
tion signal has enabled the extracellular
screening of the amyloidogenic potential of
whole proteomes and also of anti-amyloido-
genic compounds.8,9
The lack of natural intracellular amyloid
proteinopathies in bacteria and the fact that
expressing any amyloidosis-related human
protein in E. coli leads to the formation of
inclusion bodies, as many other heterologous
mammalian proteins do, initially provoked the
dismissal of bacteria as model organisms for
studies on protein amyloidoses. Furthermore,
although inclusion bodies exhibit amyloid fea-
tures, they do not hamper bacterial viability in
a significant way.10 Interestingly, aggregation
is a natural resource in some bacterial proteins
in which irreversible structural changes are
used to transit across distinct, mutually exclu-
sive, functional states.1 This is the case of the
replication protein RepA of the Pseudomonas
plasmid pPS10,11 which undergoes a transition
through three association states, each of them
linked to a defined function: from stable solu-
ble dimers (transcriptional repressors of repA
gene expression), RepA dissociates into meta-
stable monomers (acting as plasmid DNA rep-
lication initiators), which then aggregate as
oligomers that inhibit new rounds of DNA rep-
lication (by holding together two plasmid mol-
ecules through their replication origins).12-15
In all these cases, binding to distinct DNA
sequences in the plasmid triggers allosteric
conformational changes that affect the struc-
ture of the N-terminal dimerization winged-
helix domain (WH1).16 While tracking the
molecular basis for the functional aggregation
of RepA, in 2007 we reported that its isolated
WH1 domain, in its mutant variant A31V, was
able to assemble into amyloid fibers, built on
the core amyloidogenic stretch L26VLCAV-
SLI34 and upon a conformational change pro-
moted by transient WH1 binding to a short
plasmid-specific dsDNA sequence.17 We
proved that, similarly to its action enabling
DNA replication initiation through RepA
monomerization,13,16 dsDNA acted as an allo-
steric effector on RepA-WH1 amyloidogenesis
by enhancing its assembly into amyloid
fibers.17 Furthermore, we showed that a small
organic molecule (S4-indigo) was able to
inhibit such a process by competing with DNA
for the binding to RepA-WH1 in vitro.18 Aim-
ing to characterize RepA-WH1 amyloidogene-
sis in vivo, we discovered that expressing
fusions of the bacterial protein to a fluorescent
protein tracer (mCherry/mRFP), thus replacing
the natural C-terminal WH2 domain in
RepA,12,13 generated in E. coli a synthetic
amyloid proteinopathy that severely reduced
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bacterial proliferation and finally led to cell
death.19 These in vivo generated aggregates
templated the amyloid conformation on soluble
RepA-WH1 molecules in vitro,19 as they also
did in a mutant variant-specific way in vivo,20 a
signature for prion and prion-like proteins.
These findings were already discussed in
another publication in this journal dated in
2011,21 and thus will not be treated extensively
again here. Instead, we will now review novel
results recently reported on the RepA-WH1
prionoid and provide additional insight on the
topic.
Structural Polymorphism in RepA-WH1:
from Amyloid Nano-Springs and Tubes to
Chimeric Yeast Prions
Structural polymorphism, i.e. the alternative
ways in which a particular macromolecule can
arrange its tertiary and/or quaternary structures, is
an intrinsic feature of amyloid assemblies.22 Poly-
morphism has been described from the subtleties
of the packing of protein side chains and strands
in cross-b assemblies to the pitch of twisted
amyloid fibers.23,24 Moreover, the ways and
strengths in which phenotypes associated to a par-
ticular amyloidogenic protein show up, either in
disease or within a physiological function, bear an
intimate relation with polymorphism.25,26
Recent electron microscopy (EM) and
atomic force microscopy (AFM) studies on the
amyloid fibers, assembled in vitro by templat-
ing on soluble RepA-WH1 molecules the amy-
loid conformation present in the RepA-WH1-
mCherry aggregates purified from bacteria,
revealed that the characteristic 25 nm-wide
amyloid fibers are actually composed of several
coiled filaments, each of them with 4 nm
width (Fig. 1A).27 In turn, these filaments con-
sist either in a single or a double thread of
RepA-WH1 molecules that, with the limitations
imposed by the low resolution of the EM recon-
struction, are built by distorted monomers. This
was inferred from the loose fit of a model based
on the crystal structure of a replication-compe-
tent monomeric WH1 domain into the EM vol-
ume, as well as from circular dichroism (CD)
spectra showing an increase in b-sheet structure
upon RepA-WH1 assembly, as expected in any
amyloidogenesis.27 Polymorphism is thus
FIGURE 1 (See next page). Overview of RepA-WH1 amyloidogenesis, remarking hierarchical
assembly in vitro (A) and phase transitions in vivo (B,C). (A) Stable dimers of RepA-WH1 (dWH1)
undergo a structural transformation upon transient, low affinity binding to dsDNA, thus resulting in
metastable, aggregation-prone monomers (mWH1*).13 The core of the WH domain is colored
cyan, whereas segments showing significant conformational changes are in blue. The amyloido-
genic peptide L26VLCAVSLI34 is depicted in red, with the side-chain of the hyper-amyloidogenic
mutant residue A31V shown as spheres.17 Binding of dsDNA (yellow) to dWH1 disrupts the dimer-
ization interface, thus generating partially unfolded mWH1* monomers which assemble as helical
amyloid tubular filaments.17,27 Binding of RepA-WH1 to dsDNA, and thus amyloidogenesis, can be
competed by molecules of S4-indigo (spheres),18 whereas the conformation specific antibody
B3h7 (magenta) inhibits the assembly of RepA-WH1 oligomers into filaments.38 Filaments further
associate laterally and coil to generate the mature amyloid fibers (background EM).17,27 (B) Elec-
tron micrograph showing an ultra-thin section through an E. coli cell incubated with the B3h7 anti-
body (arrows/dots: gold-conjugated secondary anti-mouse antibody), which reveals the
preferential location of pre-amyloidogenic RepA-WH1 aggregates at the nucleoid (N; green dashed
line).38 A fluidized C-type aggregate hydrogel is also outlined (cyan dotted line).39 (C) E. coli cells
growing in microfluidic channels and expressing the prionoid.39 RepA-WH1 amyloid aggregates
show two distinct appearances, i.e. single comet-like (C) aggregates behaving as a fluidized hydro-
gel that readily splits on cell division; or multiple globular (G) cytotoxic aggregates with the com-
pactness characteristic of typical amyloid plaques.39 While the phase transition from the C to the G
aggregates occurs spontaneously in vivo, the reverse uphill transition is promoted by a single cell
factor: the Hsp70 chaperone DnaK.39
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manifested at three levels of increasing com-
plexity: the number of threads that constitute
the amyloid filaments (either one or two); the
number of filaments per fiber bundle (mode
value, 6); and variations in the pitch (on aver-
age, 64 nm) of the superhelix that results from
twisting several filaments into the mature
fibers. Disregarding if the assembly of the
fibers was triggered by dsDNA or by templat-
ing with purified RepA-WH1-mCherry seeds,
and by either leaving the samples to stand
in the fridge or agitating them at higher temper-
atures, which respectively retards or accelerates
amyloidogenesis, the fibers generated exhibit
44 Giraldo et al.
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the aforementioned polymorphism.27 Interest-
ingly, the overall architecture of the twisted
RepA-WH1 amyloid filaments can be
described as hollow springs (single) or tubules
(double filaments) with an axial cavity with a
diameter around 2.5 nm. The latter is close to
the average dimension of a similar cavity in the
short tubular proteotoxic oligomers assembled
by a-synuclein.28 If this is a mere coincidence
or if it points to a common mechanism of cyto-
toxicity for both proteins (e.g., the assembly of
pores at membranes) remains to be determined.
Regarding the lateral association of RepA-
WH1 filaments, it is known for other amyloid
fibers that divalent anions, in particular SO4
2¡,
play a role in bridging them together, side-by-
side.28-30 In the crystal structure of a RepA-WH1
dimer (PDB entry 1HKQ),13 two symmetry-
relatedmolecules were in contact through a PO4
3¡
ion, which established a triple salt bridge between
Lys85 in one molecule and Lys62 and His63 in
the other. During the crystallization attempts, it
became evident that incubation with monovalent
anions (such as Cl¡ or acetate) did not result in
crystal growth, whereas SO4
2¡ rendered poorer
diffracting crystals, although this anion yielded the
best fibers. The dependence on multivalent anions
for RepA-WH1 crystallization matches their
requirement in the lateral association of amyloid
filaments to build the mature fibers. This could be
interpreted as resulting from the overall electro-
positive charge of the RepA-WH1 molecule,31
because lowering the ionic strength enhances the
dissociation of the fiber ends to the point of releas-
ing their constituent filaments.27
What we have learnt on the structure of RepA-
WH1 fibers opens an intriguing possibility: that
the kind of assembly that monomers of this pro-
tein build upon amyloidogenesis could bear
some relation to the regulatory complexes of the
full-length RepA protein that inhibit new rounds
of amplification in recently replicated plas-
mids.15 This hypothesis, that needs experimental
support, would imply that such regulatory com-
plexes would be a new case of functional amy-
loid and so the cytotoxic RepA-WH1 prionoid
would be the outcome of decoupling amyloido-
genesis from its natural linkage toWH2 and plas-
mid replication,12,13 thus unveiling the
proteotoxic potential typical of amyloids.
Aiming to test in vivo the amyloidogenic
potential of the L26VLCAVSLI34 stretch in
RepA, 1-5 repeats of this sequence were used to
replace, following the design of a parallel
superpleated b-structure,32 the oligopeptide Q/
N-rich repeats at the N-terminal domain yeast
protein Sup35p that, in its aggregated state,
constitutes the [PSIC] prion.33 As previously
proved for a number of other mutant and heter-
ologous sequences,34-36 the resulting chimeric
protein enables an epigenetically inheritable
prion, named [REP-PSIC],33 capable of read-
ing-through the stop codon UAG, the pheno-
type characteristic of [PSIC],5 provided that at
least three repeats of the bacterial-related
sequence were present.33 The simultaneous
presence of hydrophobic (RepA-WH1 derived)
and polar (from the Sup35p scaffold) sequences
in [REP-PSIC] results in a gradation of weak
prion phenotypes/variants, as assessed by the
pink color of colonies and the generation of
very large aggregates, as evident in semi-dena-
turing detergent agarose gel electrophoresis
(SDD-AGE).33 Interestingly, biophysical analy-
ses of these functional prion variants revealed
that the presence of the hydrophobic RepA-
WH1 repeats within the Sup35p prion domain
increased the b-sheet structure while resulting
in the formation of oligomers, not fibers as for
the wild-type prion. The generation of [REP-
PSIC] variants, which are mitotically stable in
terms of propagation, illustrates the feasibility
of engineering phenotypic traits in prions by
fully exploiting the structural polymorphism of
amyloids, from oligomers to fibers, as a con-
structive resource.37
DNA and Hsp70-Modulated Phase
Transitions in RepA-WH1
Amyloidogenesis
The effect of dsDNA as an allosteric effector
of protein amyloidogenesis in vitro was a semi-
nal discovery in RepA-WH1 research.17 How-
ever, the evidence for a similar process in vivo
was indirect, i.e., a role of DNA in promoting
RepA-WH1 amyloidogenesis in E. coli cells
was inferred from an increase in the number
and size of protein aggregates when the vector
AMYLOID POLYMORPHISM AND PHASE TRANSITIONS IN BACTERIA 45
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expressing the prionoid carried tandem repeats
of the DNA sequence that efficiently promoted
amyloidogenesis in vitro.19 The development
of a monoclonal antibody (termed B3h7), char-
acterized in vitro as specific for a pre-amyloid
oligomeric conformation on-pathway to mature
RepA-WH1 fibers (Fig. 1A),38 has recently
made possible to unveil, through immuno-elec-
tron microscopy (iEM) (Fig. 1B), that in E. coli
cells expressing the prionoid the very first amy-
loid oligomeric precursors are found at the bac-
terial nucleoid,38 as expected from the known
ability of DNA to promote RepA-WH1 amyloi-
dogenesis in vitro17,18 and possibly from the
original function of the WH1 domain when, in
the whole RepA, controls plasmid DNA repli-
cation.15 It was found, also by iEM, that amy-
loid particles exceeding 100 nm in diameter
are placed out of the nucleoid territory,39 as
expected if entropic exclusion by the nucleoid
were playing a mayor role in the localization of
the aggregates. These findings could have
implications for the preferential or alternative
tropism of amyloid aggregates toward the cyto-
plasm or the nucleus in some human neurode-
generative proteinopathies, or in the case of
proteins such as FUS, whose ability to assem-
ble functional ribonucleoparticles in either
location becomes impaired in amyotrophic lat-
eral sclerosis and frontotemporal dementia.40-42
Concerning the intracellular inclusions formed
by amyloidogenic proteins either in the cytoplasm
or in the nucleus of eukaryotic cells, it is remark-
able the recent description of the existence of
phase transitions between soluble, hydrogel and
fibrilar states, in some cases through intermediates
with the appearance of liquid droplets.40-44 Such
partitions imply changes in the association state
beyond the quaternary structure, generating the
so-called quinary structural level, having conse-
quences for the functionality and bioavailability
of the macromolecules involved. In many instan-
ces, these are proteins bearing domains with
amino-acid compositions biased toward low com-
plexities. In the case of Q/N/G-rich domains,
phase transitions have been related with the pack-
age of mRNA in stress/P-granules and are rele-
vant in amyloidogenesis.40-42 Interestingly, albeit
RepA-WH1 lacks such simplified amino-acid
composition and has a very stable fold in its native
state, when assembled as cytoplasmic aggregates
in vivo, exhibits similar phase transitions, the first
instance in which this has been observed in bacte-
ria.39 In these experiments, a combination of fluo-
rescence microscopy and microfluidics was used,
because this enabledmonitoring bacterial prolifer-
ation and the dynamics of RepA-WH1 aggrega-
tion at the level of multiple single cell lineages,
for many generations (up to 200) and under con-
trolled environmental conditions. For studies on
amyloidosis, surveying the physiology of bacteria
in microfluidic devices surpasses the approaches
based on agarose pads in terms of the number of
generations achievable before the cessation of
growth, the feasibility to track lineages and the
ease to inject into, or extract from, the cultures
diverse molecules of interest. Two clearly distinct
RepA-WH1 aggregates became evident at the
microfluidic device (Fig. 1C): i) multiple globu-
lar, compact cytotoxic (G) particles that inhibit
cell division; ii) a single, comet-shaped (C) aggre-
gate that appears to be fluidized, i.e. elongates,
contracts and undulates along the cell axis and
readily splits between the daughter cells on cyto-
kinesis.39 The outcome is that while bacteria
expressing theG-type aggregates show a tendency
toward filamentation and cells die after a few gen-
erations, those bearing the C-type aggregates
keep dividing indefinitely at a reasonable rate. In
an isogenic population expressing RepA-WH1,
bacteria at distinct microfluidic channels propa-
gate for generations one or the other type of aggre-
gates, although interconversion (more commonly
C to G) occurs at low rates.39 We also explored
the effect of the Hsp70 chaperone DnaK on
RepA-WH1 amyloidogenesis, because it is cen-
tral in counteracting protein aggregation in bacte-
ria and a role for DnaK in the activation of RepA-
type proteins for plasmid replication was recog-
nized for long.11 It is the activity of DnaK, i.e., its
expression induced from a regulated promoter vs.
its specific inhibition with myricetin, what deter-
mines the balance and switching (phase transition)
between both kinds of aggregates: DnaK pro-
motes the conversion of most cells to the elon-
gated phenotype, whereas its inactivation results
in the population dominated by the globular phe-
notype.39 iEM studies revealed that DnaK is pref-
erentially located at the aggregate with an
elongated and fluidized appearance, which
46 Giraldo et al.
D
ow
nl
oa
de
d 
by
 [C
SI
C 
Ce
ntr
o d
e I
nv
es
tig
ac
ion
es
 B
iol
og
ica
s] 
at 
04
:46
 27
 A
pr
il 2
01
6 
constitutes a territory with a clearly different den-
sity toward the electrons compared with that
observed for the globular aggregates.39 Therefore
this Hsp70 chaperone, most likely through its
aggregate remodeling activity, is the factor deter-
mining quinary structural phase transitions for
RepA-WH1 in the bacterial cytoplasm. On the
contrary, the bacterial ClpB (Hsp100) chaperone
has no apparent contribution to this effect. Com-
ing to the point, the work carried out with our syn-
thetic bacterial model prionoid suggests that the
long sought cell factor(s) that would ameliorate
amyloid cytotoxicity in human proteinopathies
might be Hsp70 chaperones by promoting the
assembly of pro-amyloidogenic proteins as non-
fibrilar hydrogels.
FURTHER PERSPECTIVES
Ongoing research on the bacterial prionoid
RepA-WH1 aims to trace a scheme of the
molecular basis for amyloid cytotoxicity in
such a minimal host as Escherichia coli,
with the ambition of providing clues on the
undeniably more complex mammalian amy-
loid proteinopathies. Such endeavor spans
from a systems biology perspective, to high-
light gene networks and metabolic pathways
related to amyloid disease, to bottom-up
approaches based on reconstructive, cytomi-
metic biochemistry performed with lipid
vesicles.
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